Atrial fibrillation (AF) ablation carried out in an inpatient setting is associated with higher rates of early mortality and subsequent complications when compared with outpatient AF ablation, a new study finds
Because it reduces the inflammation that was preventing the body from recovering in the first place
Food and Drug Administration (FDA) has been vocal about the risks associated with improperly prepared compounded drugs, establishing a clear need for the verification checklist that follows
La droga semaglutida , utilizada en un comienzo en pacientes con diabetes tipo 2, pero que ha demostrado buenos resultados en personas con sobrepeso, y que hasta el momento se presenta de forma inyectable, fue probada en versin de pldoras en pacientes con obesidad
Documented dose ranges: Route notes: Intramuscular injection (deltoid, gluteal) is the most commonly cited route in community protocols
Key Takeaways: 1) Compounded semaglutide from Brightmeds is an alternative to FDA-approved drugs and is not FDA-approved
